These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Integrated study of Quercetin as a potent SARS-CoV-2 RdRp inhibitor: Binding interactions, MD simulations, and In vitro assays. Metwaly AM; El-Fakharany EM; Alsfouk AA; Ibrahim IM; Elkaeed EB; Eissa IH PLoS One; 2024; 19(12):e0312866. PubMed ID: 39625895 [TBL] [Abstract][Full Text] [Related]
3. The effect of early versus late remdesivir treatment in hospitalized mild to moderate COVID-19 patients in the Omicron era: A retrospective study. Ryu BH; Lee JY; Lee SH Medicine (Baltimore); 2024 Jul; 103(29):e39035. PubMed ID: 39029053 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients. Mozaffari E; Chandak A; Ustianowski A; Rivera CG; Ahuja N; Jiang H; Berry M; Okulicz JF; Amin AN Clin Ther; 2024 Oct; 46(10):778-784. PubMed ID: 39244489 [TBL] [Abstract][Full Text] [Related]
5. Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study. Saffar H; Nabati M; Saffar N; Yazdani J BMC Cardiovasc Disord; 2024 Dec; 24(1):700. PubMed ID: 39633288 [TBL] [Abstract][Full Text] [Related]
6. Hospital-Level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort Study. Alexander GC; Garibaldi BT; An H; Andersen KM; Robinson ML; Wang K; Xu Y; Betz JF; Wu AW; Fisher A; Egloff SA; Sands KE; Mehta HB Med Care; 2025 Jan; 63(1):9-17. PubMed ID: 39422569 [TBL] [Abstract][Full Text] [Related]
7. Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients. De Forni D; Poddesu B; Cugia G; Chafouleas J; Lisziewicz J; Lori F PLoS One; 2022; 17(11):e0276751. PubMed ID: 36355808 [TBL] [Abstract][Full Text] [Related]
8. A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic. Kheirabadi D; Haddad F; Mousavi-Roknabadi RS; Rezaeisadrabadi M; Dehghan H; Fazlzadeh A J Med Virol; 2021 May; 93(5):2705-2721. PubMed ID: 33463727 [TBL] [Abstract][Full Text] [Related]
9. Public engagement to refine a whole-school intervention to promote adolescent mental health. Bonell C; Hope S; Sundaram N; Lloyd-Houldey O; Michalopoulou S; Scott S; Nicholls D; Viner R Public Health Res (Southampt); 2024 Dec; ():1-22. PubMed ID: 39636228 [TBL] [Abstract][Full Text] [Related]
10. Does Remdesivir Lower COVID-19 Mortality? A Subgroup Analysis of Hospitalized Adults Receiving Supplemental Oxygen. Potter GE; Proschan MA Stat Med; 2024 Dec; 43(28):5285-5299. PubMed ID: 39385581 [TBL] [Abstract][Full Text] [Related]
11. Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase Metwaly AM; Elkaeed EB; Alsfouk AA; Ibrahim IM; Elkady H; Eissa IH Antivir Ther; 2024 Dec; 29(6):13596535241305536. PubMed ID: 39639531 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of early administration of remdesivir in hemodialysis patients with COVID-19: A case report and literature review. Oshiro N; Kinjo T; Aharen D; Kudo Y; Katsuren E; Omine K; Nakamura T; Zamami R; Ishida A; Miyagi K; Nakamatsu M; Yamamoto K; Kusunose K; Fujita J; Ohya Y; Kohagura K Medicine (Baltimore); 2024 Nov; 103(48):e40650. PubMed ID: 39612460 [TBL] [Abstract][Full Text] [Related]
13. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers. McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288 [TBL] [Abstract][Full Text] [Related]
14. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults. Huang Y; Trollor JN; Foley KR; Arnold SRC Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050 [TBL] [Abstract][Full Text] [Related]
15. Interventions to improve mental health and well-being in care-experienced children and young people aged less than 25: the CHIMES systematic review. Evans R; MacDonald S; Trubey R; Noyes J; Robling M; Willis S; Vinnicombe S; Boffey M; Wooders C; El-Banna A; Melendez-Torres GJ Public Health Res (Southampt); 2024 Dec; 12(14):1-124. PubMed ID: 39641478 [TBL] [Abstract][Full Text] [Related]
16. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610 [TBL] [Abstract][Full Text] [Related]
17. Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition. Fox T; Hunt BJ; Ariens RA; Towers GJ; Lever R; Garner P; Kuehn R Cochrane Database Syst Rev; 2023 Jul; 7(7):CD015775. PubMed ID: 37491597 [TBL] [Abstract][Full Text] [Related]
18. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis. Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741 [TBL] [Abstract][Full Text] [Related]
19. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]